Network and pathway-based analysis of candidate genes associated with esophageal adenocarcinoma

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• Esophageal adenocarcinoma (EA) research has focused on pathogenesis, treatment, and prognosis, but molecular mechanisms remain underexplored.
• Understanding EA's molecular underpinnings is crucial for advancing gene function knowledge and identifying therapeutic targets.

Purpose of the Study:

• To conduct a comprehensive analysis of esophageal adenocarcinoma (EA) genes, focusing on their biological functions and interactions.
• To elucidate the molecular mechanisms and pathogenetic pathways involved in EA development.

Main Methods:

• Systematic literature review of 458 publications to identify 109 EA-related genes.
• Utilized gene enrichment assays, pathway enrichment assays, and pathway crosstalk analysis.
• Extracted an EA-specific subnetwork to identify key molecular players.

Main Results:

• Identified significant biological processes and pathways related to apoptosis, metabolism, cancer, and drug reactions.
• Discovered 12 novel genes within the EA-specific network, including *PTHLH*, *SUMO2*, *TYMS*, *APP*, *PTGIR*, *SP1*, *UBC*, *COL1A1*, *GSTO1*, *TRAF6*, *BMP7*, and *RAB40B*.
• These novel genes may hold potential for clinical applications in EA management.

Conclusions:

• Integrated pathway and network analyses provide a deeper understanding of EA's pathogenetic mechanisms.
• The findings offer a foundation for selecting potential molecular targets for future research and clinical exploration in esophageal adenocarcinoma.